Waddell & Reed Financial’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
MCMC
FLAM
Waddell & Reed Financial's CDNA Position: Q1 2021 in Review
Waddell & Reed Financial reduced its CareDx (CDNA) stake by 12% in Q1 2021, selling an estimated $16.7M and leaving 1,527,424 shares worth $104M. The position accounts for 0.21% of the portfolio, ranked #141.
Waddell & Reed Financial first reported a position in CDNA in Q4 2018 and has held it in 10 quarters since. The position peaked at $126M in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.
- Waddell & Reed Financial held 1,527,424 shares of CareDx worth $104M as of Q1 2021.
- Waddell & Reed Financial sold 214,543 CareDx shares in Q1 2021, an estimated $16.7M.
- CareDx made up 0.21% of Waddell & Reed Financial's portfolio in Q1 2021, its #141 holding.
- Waddell & Reed Financial first reported a position in CareDx in Q4 2018 and has held it in 10 quarters since.
- Waddell & Reed Financial's CareDx position peaked at $126M in Q4 2020.
- 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.
Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.